Researchers identify target to enhance NK cell function for liver cancer therapy in Korea New insights into immune cell dynamics could lead to innovative therapies for cancer in Korea.
In his book The Mathematical Universe, mathematician William Dunham wrote of John Venn’s namesake legacy, the Venn diagram, “No one in the long history of mathematics ever became better known ...
Excalidraw is an innovative online whiteboarding tool that uses the power of artificial intelligence (AI) to convert simple text prompts into detailed, professional-quality diagrams. Whether you ...
Elon Musk said a third person has received an implant from his brain-computer interface company Neuralink, one of many groups working to connect the nervous system to machines. “We’ve got ...
Founded in 2016, the Fremont, Calif-based Neuralink is currently working on offering digital autonomy to those with quadriplegia. By embedding threads containing electrodes within the human brain, ...
The implant, called N1, was installed last year by neurosurgeons working with Neuralink, Elon Musk’s brain-interface company. The possibility of listening to neurons and using their signals to ...
Elon Musk’s Neuralink suggests that a human patient might have successfully used the company’s brain chip to remotely control a robot. A short video clip posted Thursday shows a robot arm ...
Elon Musk said a third person has received an implant from his brain-computer interface company Neuralink, one of many groups working to connect the nervous system to machines. “We've got ...
This month, Neuralink, the brain-computer interface (BCI) company co-founded by Elon Musk, reached a significant milestone by successfully implanting its device in a third human patient.
A third person received a brain implant from Neuralink. Elon Musk said during an interview that Neuralink wants to implant the experimental devices in more people this year. Two other patients ...
Elon Musk, CEO of Tesla and Neuralink, has disclosed that his brain-computer interface (BCI) company has implanted devices in three human subjects, with all showing promising results. Speaking at ...